Stockscreener 앱 받기
115.79
0.24%
-0.28
전일 마감가:
$116.07
열려 있는:
$115.155
하루 거래량:
12.80M
Relative Volume:
0.97
시가총액:
$286.28B
수익:
$64.93B
순이익/손실:
$18.26B
주가수익비율:
15.92
EPS:
7.2751
순현금흐름:
$12.36B
1주 성능:
-6.49%
1개월 성능:
-5.04%
6개월 성능:
+36.69%
1년 성능:
+23.18%
1일 변동 폭
$113.82
$116.36
1주일 범위
$113.82
$123.70
52주 변동 폭
$73.31
$125.14
머크앤드컴퍼니 Stock (MRK) Company Profile
명칭
Merck Co Inc
전화
908-740-4000
주소
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, NVS, AZN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
115.79 | 286.97B | 64.93B | 18.26B | 12.36B | 7.2751 |
|
LLY
Lilly Eli Co
|
990.33 | 878.04B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
240.40 | 577.48B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
230.11 | 410.83B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
NVS
Novartis Ag Adr
|
160.12 | 307.23B | 54.72B | 14.02B | 15.32B | 7.1855 |
|
AZN
Astrazeneca Plc
|
194.22 | 306.31B | 58.80B | 10.24B | 8.98B | 3.2788 |
머크앤드컴퍼니 Stock (MRK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-13 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2026-01-08 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-10-13 | 재개 | Citigroup | Neutral |
| 2025-09-17 | 다운그레이드 | Berenberg | Buy → Hold |
| 2025-05-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Neutral |
| 2025-02-18 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-02-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-01-08 | 다운그레이드 | Truist | Buy → Hold |
| 2024-12-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | 재개 | BofA Securities | Buy |
| 2024-12-04 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-11 | 다운그레이드 | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-03-11 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2024-01-04 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-27 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | 업그레이드 | UBS | Neutral → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Hold |
| 2023-04-13 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-03-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-03-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 개시 | Jefferies | Buy |
| 2023-02-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-10-10 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-09-14 | 업그레이드 | Berenberg | Hold → Buy |
| 2022-07-06 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 재개 | SVB Leerink | Outperform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 개시 | Goldman | Buy |
| 2021-12-16 | 개시 | Daiwa Securities | Neutral |
| 2021-12-13 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-12-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-11-29 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-11-01 | 업그레이드 | Argus | Hold → Buy |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-20 | 다운그레이드 | Argus | Buy → Hold |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-08-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-06-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-16 | 개시 | SVB Leerink | Outperform |
| 2019-07-03 | 개시 | Mizuho | Buy |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-05-13 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 재확인 | Citigroup | Buy |
| 2018-10-09 | 재개 | Guggenheim | Buy |
| 2018-04-23 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-04-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-03-12 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-02-07 | 재확인 | Morgan Stanley | Equal-Weight |
| 2018-01-16 | 업그레이드 | SunTrust | Hold → Buy |
모두보기
머크앤드컴퍼니 주식(MRK)의 최신 뉴스
Merck & Co., Inc. $MRK Holdings Cut by LOM Asset Management Ltd - MarketBeat
Orion Porfolio Solutions LLC Has $9.65 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
GW&K Investment Management LLC Has $23.76 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Edgar Lomax Co. VA - MarketBeat
Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market - GlobeNewswire Inc.
Merck & Co., Inc. $MRK Shares Sold by Smith Chas P & Associates PA Cpas - MarketBeat
Merck & Co., Inc. $MRK Holdings Lifted by Dimensional Fund Advisors LP - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 1.4%Should You Sell? - MarketBeat
Merck & Co. Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
AI-Powered Tempus Inks New Multi-Year Merck DealTempus AI (NASDAQ:TEM) - Benzinga
Merck to collaborate with Tempus AI on precision oncology - Seeking Alpha
Victory Capital Management Inc. Has $397.27 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Oak Grove Capital LLC Sells 21,515 Shares of Merck & Co., Inc. $MRK - MarketBeat
Focus Partners Advisor Solutions LLC Grows Holdings in Merck & Co., Inc. $MRK - MarketBeat
Kahn Brothers Group Inc. Sells 56,715 Shares of Merck & Co., Inc. $MRK - MarketBeat
Laurel Wealth Advisors LLC Trims Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Down 1.9%Here's What Happened - MarketBeat
Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views? - Finviz
Merck & Co., Inc. $MRK Position Lifted by Kingsview Wealth Management LLC - MarketBeat
Elo Mutual Pension Insurance Co Has $24.19 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Company, Inc. (MRK) Stock Analysis: Healthcare Titan with Strong Buy Ratings and Growth Potential - DirectorsTalk Interviews
Fisher Asset Management LLC Sells 945,571 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck Scientists Launch Research Award to Support Rising Chemists of Color - CSRwire
Antibiotics Market - GlobeNewswire Inc.
Davis R M Inc. Lowers Stake in Merck & Co., Inc. $MRK - MarketBeat
Bahl & Gaynor Inc. Sells 1,406,091 Shares of Merck & Co., Inc. $MRK - MarketBeat
River Wealth Advisors LLC Boosts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Rafferty Asset Management LLC - MarketBeat
Quantbot Technologies LP Increases Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Bedell Frazier Investment Counselling LLC Sells 34,557 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Diversify Wealth Management LLC - MarketBeat
MRK SEC FilingsMerck & Co 10-K, 10-Q, 8-K Forms - Stock Titan
Merck & Co Inc says FDA sets PDUFA date of June 19, 2026 for Welireg and Keytruda - marketscreener.com
Merck & Co Inc Says FDA Sets PDUFA Date Of June 19, 2026 For Welireg And Keytruda - TradingView
Tounjian Advisory Partners LLC Sells 10,436 Shares of Merck & Co., Inc. $MRK - MarketBeat
TIAA Trust National Association Sells 16,354 Shares of Merck & Co., Inc. $MRK - MarketBeat
Harvest Portfolios Group Inc. Buys 57,528 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Erste Asset Management GmbH - MarketBeat
Artisan Partners Limited Partnership Increases Position in Merck & Co., Inc. $MRK - MarketBeat
Argent Trust Co Sells 39,601 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by American Century Companies Inc. - MarketBeat
Merck & Co. Inc. stock outperforms competitors on strong trading day - MarketWatch
A Look Into Merck & Co Inc's Price Over Earnings - Benzinga
Merck to lay off around 150 employees at US site amid slump in Gardasil sales - Reuters
Xponance Inc. Lowers Position in Merck & Co., Inc. $MRK - MarketBeat
Handelsbanken Fonder AB Sells 26,136 Shares of Merck & Co., Inc. $MRK - MarketBeat
Generali Investments Management Co LLC Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
FUKOKU MUTUAL LIFE INSURANCE Co Has $37.61 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Hohimer Wealth Management LLC Purchases 9,170 Shares of Merck & Co., Inc. $MRK - MarketBeat
Andra AP fonden Has $45.69 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
US Bancorp DE Lowers Holdings in Merck & Co., Inc. $MRK - MarketBeat
머크앤드컴퍼니 (MRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.67%
0.53%
자본화:
|
볼륨(24시간):